15-78009032-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_144572.2(TBC1D2B):c.2353C>T(p.Arg785*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000138 in 1,453,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
TBC1D2B
NM_144572.2 stop_gained
NM_144572.2 stop_gained
Scores
4
2
1
Clinical Significance
Conservation
PhyloP100: 6.15
Genes affected
TBC1D2B (HGNC:29183): (TBC1 domain family member 2B) Predicted to enable GTPase activator activity. Predicted to be involved in activation of GTPase activity and intracellular protein transport. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-78009032-G-A is Pathogenic according to our data. Variant chr15-78009032-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3058247.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBC1D2B | NM_144572.2 | c.2353C>T | p.Arg785* | stop_gained | 10/13 | ENST00000300584.8 | NP_653173.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBC1D2B | ENST00000300584.8 | c.2353C>T | p.Arg785* | stop_gained | 10/13 | 5 | NM_144572.2 | ENSP00000300584.3 | ||
TBC1D2B | ENST00000409931.7 | c.2353C>T | p.Arg785* | stop_gained | 10/13 | 1 | ENSP00000387165.3 | |||
TBC1D2B | ENST00000472786.1 | n.1319C>T | non_coding_transcript_exon_variant | 3/4 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1453470Hom.: 0 Cov.: 30 AF XY: 0.00000139 AC XY: 1AN XY: 722004
GnomAD4 exome
AF:
AC:
2
AN:
1453470
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
722004
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
TBC1D2B-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 29, 2024 | The TBC1D2B c.2353C>T variant is predicted to result in premature protein termination (p.Arg785*). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. Protein-truncating variants upstream and downstream of this variant have been reported in the literature and also observed at PreventionGenetics (internal database). Therefore, this variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -35
Find out detailed SpliceAI scores and Pangolin per-transcript scores at